AAAP offers many committees within the organization for our members to interact with colleagues. Get involved and make a difference within the organization!
Carl Sullivan, MD, Chair and Viral Goradia, MD, Co-Chair
The Controversial Issues Committee arose several years ago out of the Chronic Pain Task Force that was under the auspices of the Treatment Section. Its mission is to use the principles and lessons of Addiction Psychiatry to help sort out proper medical practice in areas of uncertain and conflicting evidence.
Jeffrey DeVido, MD, Chair, and Ramzi Mardam Bey, MD, Co-Chair
The primary role of the Education Committee is to support high quality training for PGY I-V Addiction Psychiatry residents, promote the quality of teaching and clinical experience in the addictions in general psychiatry residency programs, and encourage medical students interested in the field of Addiction Psychiatry.
Marijuana Special Interest Group
Kevin Hill, MD, Chair
The marijuana special interest group aims to inform both treatment of marijuana addiction and marijuana-related policies from an evidence-based perspective. Members share our clinical experiences treating marijuana addiction as well as the challenges and concerns we have about the changing landscape of marijuana policy as state after state faces questions about medical marijuana and legalization of marijuana.
Rebecca A. Payne, MD, Chair, Jose Vito, MD, Co-Chair , and Austin Lin, MD, Co-Chair
The Membership Committee strives to anticipate, ascertain and address the needs and wishes of its membership. The Membership Committee asserts that members are the organization’s most important asset and through constant dialogue, works to continue to improve member benefits and experience. The Membership Committee welcomes members at all levels of their career who would like to become involved.
CPD (Continuing Professional Development) Committee
Dean D. Krahn, MS, MD, Margaret Mary Kotz, DO, Co-Chairs, and Michael Goedde, MS, MD, Associate Chair
AAAP thinks that the continuing professional development (CPD) of our healthcare providers is extremely important. The CPD committee was formed because of the growing need for members to have access to educational resources that will be clinically useful to the field and to increase the likelihood that practitioners actually implement these treatments in their own practices and programs. This committee reviews what treatments work, how do we know they work and how can we put them into practice? The committee was recently merged with 2 other committees: 1) The Publications and Products Committee, which produces and oversees the development and dissemination of AAAP educational products, generates products and works with other AAAP committees to facilitate the development of products and 2) The MOC/EBT Committee, which was formed because of the growing need for members to be informed about maintenance of certification in addiction psychiatry and evidence-based treatment in addictions.
John Fromson, MD, Chair
The Physician Health committee serves as an educational and policy planning resource for clinical, administrative and research issues related to the identification and treatment of physicians with psychoactive substance use or other psychiatric disorders as well as factors relating to the prevention of such illnesses.
Scientific Program Committee
Robert T. Milin MD, FRCPC, DABPN, Chair , Carla Marienfeld, MD, Chair, Thomas Penders, MD, Associate Chair, Edward Nunes, MD, Associate Chair, and Elie Aoun, MD, Associate Chair
The Annual Meeting Program and Scientific Committee is charged with developing a high-quality scientific program for the AAAP Annual Meeting and Scientific Symposium. The Program and Scientific Committee receives guidance from the Board of Directors, CME/CPD Committee and AAAP membership on topics, the development of content, selection of faculty and sessions to be offered.
Richard N. Rosenthal, MD, Section Head Chair and
Hilary S. Connery, MD, PhD, Co-Chair
The Public Policy Section is comprised of two committees (the Public Policy Committee and the Public Information Committee) with the goals of coordinating and disseminating AAAP policy recommendations and disseminating knowledge of addictive disorders to the general public. The Public Policy Section works in close collaboration with the Research, Treatment and Education Sections of AAAP to promote excellence of clinical practice in Addiction Psychiatry, to educate the public regarding substance use disorders, to promote accessibility and quality of treatment for all patients, and to support research in the field.
Kevin Gray MD, Chair and Edward Thomas Lewis III, MD, Co-Chair
The Research Section examines how recent research advances inform the contemporary practice of Addiction Psychiatry. A particular interest is determining how scientific discoveries are translated into real-world clinical practice by AAAP members and how best to ensure that the most relevant research findings are transmitted to the membership in a timely fashion to promote life-long learning.
Marc Galanter, MD, Chair
The purpose of this committee is to (1) clarify the state of research on the mode of operation of Twelve-Step programs; (2) promote clinically-related approaches, such as the dissemination of Twelve-Step facilitation to enhance psychiatrists’ ability to refer patients to such programs effectively; and (3) consider means by which psychiatric residents and fellows can best be given training on these issue.
Youth and Adolescence
David Atkinson MD, Chair, and Ximena Sanchez-Samper, MD, Co-Chair
The Child and Youth Treatment Committee seeks to identify and address issues unique to our youngest patients. The committee promotes the visibility of addiction treatment of minors by presenting symposia and workshops about child and adolescent substance abuse and distributing educational materials to a broader audience.